Fyremadel
NDC 55566-1010, ganirelix acetate, injection, solution, from Ferring Pharmaceuticals Inc..
- Product NDC
- 55566-1010
- Status
- Listed
- Labeler
- Ferring Pharmaceuticals Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204246
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55566-1010 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GANIRELIX ACETATE250 ug/.5mL
Pharmacologic classes
Decreased GnRH Secretion [PE]; Gonadotropin Releasing Hormone Receptor Antagonist [EPC]; Gonadotropin Releasing Hormone Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55566-1010-1 | 55566101001 | 1 BLISTER PACK in 1 CARTON (55566-1010-1) / 1 SYRINGE in 1 BLISTER PACK / .5 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/5f0908b5-3551-47fd-95f7-3669b0dff7f1NADAC price for package 55566101001
GET /v1/drugs/nadac/55566101001
Use it
Look up 55566-1010 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55566-1010 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55566-1010. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.